This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Apricus Biosciences Inc (APRI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 11.40M 21.40M 15.13M 7.43M
Receivables 678.00K 59.00K 678.00K 326.93K
Inventories 275.00K 336.00K 0.00 136.15K
Other Current Assets 0.00 0.00 4.44M 0.00
Total Current Assets 13.29M 22.26M 20.90M 8.19M
Property, Plant & Equipment, Gross 1.68M 1.11M 698.00K 7.94M
Accumulated Depreciation & Depletion 325.00K 156.00K 97.00K 3.55M
Property, Plant & Equipment, Net 1.36M 955.00K 601.00K 4.38M
Intangibles 0.00 0.00 0.00 2.63M
Other Non-Current Assets 162.00K 91.00K 2.38M 280.19K
Total Non-Current Assets 1.52M 1.05M 2.98M 8.42M
Liabilities & Shareholder Equity
Total Assets 14.81M 23.31M 23.88M 16.62M
Accounts Payable 860.00K 926.00K 2.28M 1.14M
Short Term Debt 0.00 0.00 0.00 4.27K
Other Current Liabilities 0.00 3.55M 4.56M 1.68M
Total Current Liabilities 6.91M 11.76M 10.77M 10.02M
Long Term Debt 4.63M 0.00 3.41M 0.00
Deferred Income Taxes 353.00K 487.00K 1.53M 0.00
Other Non-Current Liabilities 1.00M 91.00K 1.55M 1.76M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 5.98M 578.00K 6.49M 1.78M
Total Liabilities 12.89M 12.34M 17.26M 11.80M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.92M 10.97M 6.62M 4.82M
Common Par 44.00K 38.00K 30.00K 21.35K
Additional Paid In Capital 291.73M 279.00M 257.08M 224.15M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -289.85M -268.07M -251.13M -219.36M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 641.00K 0.00
Total Capitalization 6.54M 10.97M 10.03M 4.82M
Total Equity 1.92M 10.97M 6.62M 4.82M
Total Liabilities & Stock Equity 14.81M 23.31M 23.88M 16.62M
Total Common Shares Outstanding 44.33M 37.54M 29.94M 21.35M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 39.54M 34.41M 27.46M 20.02M
Diluted Weighted Shares Outstanding 39.54M 34.41M 27.46M 20.02M
Number of Employees 23 21 114 25
Number of Part-Time Employees 0 0 0 0
APRI News

APRI Apricus Biosciences Inc

Analysts Ratings for APRI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET APRI ANALYST REPORT

Brokerage Partners

APRI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs